Accreditation and Designation User Manual - OECI
Accreditation and Designation User Manual - OECI
Accreditation and Designation User Manual - OECI
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
5.2 Step 2: Payment stage 1 fee<br />
The institute receives the first payment order after approval of the application <strong>and</strong> the designation screening, <strong>and</strong><br />
before the explanatory visit.<br />
Tasks of the Executive Manager:<br />
− Sending invoices to the institutes including the signed A&D Agreement<br />
− Controlling the payments of the institutes,<br />
− Providing the A&D Chair <strong>and</strong> A&D Secretary with a copy of invoices sent to the institutes.<br />
Tasks of the A&D Secretary:<br />
− Confirming payments of the institutes to the institute <strong>and</strong> Executive Manager.<br />
The total fee depends on the designation type of the institute:<br />
Stage 1 Stage 2 Total<br />
Cancer Unit € 5.000 € 15.000 € 20.000<br />
Clinical Cancer Centre € 5.000 € 25.000 € 30.000<br />
Comprehensive Cancer Centre (CCC) € 5.000 € 25.000 € 30.000<br />
The fee of stage one is equal for all types of institutes <strong>and</strong> covers primarily the costs for application <strong>and</strong><br />
designation screening, explanatory visit, use of the e-tool during the self-assessment period, the <strong>OECI</strong> support<br />
during the self-assessment period, the organisation of meetings for the A&D Committee <strong>and</strong> A&D Board for the<br />
‘go’ decision, <strong>and</strong> labour costs of the A&D Management Unit.<br />
Difference in fee<br />
− The peer review visit in a Cancer Unit possibly takes one day instead of two full days in clinical cancer centres<br />
<strong>and</strong> CCC’s,<br />
− The peer review visit in a Cancer Unit does not include the full set of st<strong>and</strong>ards. St<strong>and</strong>ards related to chapter<br />
4 ‘Research, innovation <strong>and</strong> development’ are not assessed,<br />
− The audit team possibly includes less than four auditors.<br />
Note:<br />
There might be reasons for an institute not being able to continue the A&D programme towards the peer review<br />
visit after the self-assessment, such as: delay of the self-assessment period, ‘no go’ decision, changes in the<br />
management of the institutes etc. One year after the payment of stage 1 an institute will be reminded of its<br />
participation in the programme. The application of the institute will expire if the institute will not continue the<br />
programme within two years after the payment of stage 1. The <strong>OECI</strong> A&D Group will not return the payment of<br />
stage 1.<br />
Note:<br />
If there is a discrepancy between the designation judgement of the institute <strong>and</strong> the preliminary designation that<br />
remains after the explanatory visit, the institute shall pay the fee equal to the designation type applied for. For<br />
example: an institute that has classified itself as a clinical cancer centre <strong>and</strong> is willing to continue the programme<br />
as such, shall pay in total € 30.000 although the preliminary designation is a cancer unit.<br />
Note:<br />
If an institute decides to apply for A&D as clinical cancer centre or CCC the full set of st<strong>and</strong>ards will be assessed,<br />
including the st<strong>and</strong>ards related to chapter 4 ‘Research, innovation <strong>and</strong> development’.<br />
Owner: <strong>OECI</strong> Organisation of European Cancer Institutes<br />
Status: Revised - 24 th January 2011 - A&D Working Group<br />
Approved by: <strong>OECI</strong> <strong>Accreditation</strong> <strong>and</strong> <strong>Designation</strong> Board<br />
Chapter 5 Ten steps A&D process in detail<br />
Page 7 of 28<br />
Version 16 February 2011